Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ANPEP | P15144 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7098611 | 1.00 | KMT2A (0.55) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL8802193 | 0.89 | KMT2A (0.61) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7098818 | 0.89 | KMT2A (0.52) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7098823 | 0.89 | KMT2A (0.52) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7098602 | 0.85 | KMT2A (0.55) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7098596 | 0.85 | KMT2A (0.55) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7101421 | 0.84 | KMT2A (0.51) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7101423 | 0.84 | KMT2A (0.51) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7102396 | 0.83 | POLB (0.52) | KMT2AMEN1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7102880 | 0.83 | KMT2A (0.52) | KMT2AMEN1TSHRCYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140818-B1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | AVENTIS PHARMA INC (US) | 2003-09-10 | — | — | EP | disclosed |
| US-6329550-B1 | FOR THERAPY OF EMPHYSEMA, OSTEOPOROSIS, RHEUMATOID ARTHRITIS AND NEOPLASTIC DISEASES | AVENTIS PHARMACEUTICALS INC. | 2001-12-11 | — | — | US | disclosed |
| EP-1140818-A1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | Aventis Pharmaceuticals Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000040552-A1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | AVENTIS PHARMACEUTICALS INC. (US) | 2000-07-13 | — | — | WO | disclosed |